Hannah Bellmann

Hannah Bellmann is a EU healthcare professional working at the intersection of pharmaceutical infrastructure and the emerging medical cannabis industry. With experience at Fagron, the global pharmaceutical compounding leader, and Cansativa, Germany’s pioneering medical cannabis distribution platform, she has been closely involved in the evolution of the regulated cannabis supply chain. Today, Hannah supports Medios AG, eg Medios Pharma GmbH, one of Europe’s leading specialty pharma companies, as it enters the medical cannabis market. Her work focuses on implementing the Bedrocan product range into Medios portfolio, connecting pharmacies, producers, and healthcare stakeholders to help scale a high-quality, compliant, and patient-focused cannabis ecosystem across Europe.